Order Article Reprints

Barbe-Richaud J-B, Fattori A, Lindner V, Schuster C, Malouf G, Pencreach E, Somme L. EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers. Journal of Clinical Medicine. 2025; 14(9):3129. https://doi.org/10.3390/jcm14093129

Barbe-Richaud, Jean-Baptiste, Antonin Fattori, Véronique Lindner, Caroline Schuster, Gabriel Malouf, Erwan Pencreach, and Laura Somme. 2025. "EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers" Journal of Clinical Medicine 14, no. 9: 3129. https://doi.org/10.3390/jcm14093129

Barbe-Richaud, J.-B., Fattori, A., Lindner, V., Schuster, C., Malouf, G., Pencreach, E., & Somme, L. (2025). EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers. Journal of Clinical Medicine, 14(9), 3129. https://doi.org/10.3390/jcm14093129